Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.31 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24283027 | 0.95 | KCNA5 (0.31) | PGRKCNA5FFAR2MEN1KMT2A | |
| SCHEMBL19842733 | 0.92 | ATM (0.34) | KCNA5FFAR2MEN1KMT2AATM | |
| SCHEMBL24282912 | 0.91 | PGR (0.32) | PGRKCNA5MEN1KMT2AATM | |
| SCHEMBL19842812 | 0.91 | MEN1 (0.35) | KCNA5MEN1KMT2AATM | |
| SCHEMBL19842730 | 0.90 | MEN1 (0.32) | KCNA5MEN1KMT2AATM | |
| SCHEMBL19843237 | 0.90 | PGR (0.36) | PGRFFAR2MEN1KMT2AATM | |
| SCHEMBL19842501 | 0.89 | MEN1 (0.37) | MEN1KMT2AATM | |
| SCHEMBL19842977 | 0.88 | PGR (0.36) | PGRFFAR2MEN1KMT2AATM | |
| SCHEMBL23476464 | 0.87 | ATM (0.34) | KCNA5MEN1KMT2AATM | |
| SCHEMBL19842865 | 0.87 | KCNA5 (0.33) | PGRKCNA5FFAR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11276825-B2 | Organic molecules for use in organic devices | CYNORA GMBH (DE) | 2022-03-15 | — | — | US | disclosed |
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210184134-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES | CHRM1, C1S, DNMT3L | PGR 1964/4885KCNA5 2149/4885FFAR2 3096/4885 |
| US-11276825-B2 | Organic molecules for use in organic devices | AOX1, OR10J3, L1CAM | PGR 1651/4885KCNA5 1198/4885FFAR2 2293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.